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SurgicalSolutions
High Volume, Top Quality, and Rigorous Research:
Jefferson Sets New Standards in Pancreatic Cancer Care
Each year, Jefferson surgeons perform
over 200 pancreatic resections,
including more than 130 “Whipple
procedures” — making the hospital #1
in surgical volume for pancreatic
cancer and related diseases in the
tristate region of Pennsylvania,
New Jersey and Delaware.
“While we are very proud of what
we have achieved, there are always
opportunities for improvement,” says
Charles J. Yeo, MD, FACS, Samuel D.
Gross Professor and Chair of Surgery,
who has personally performed more
than 1,400 Whipple procedures and
treated thousands of patients with
pancreatic cancer and related diseases.
Beyond the impressive numbers, the
Jefferson Pancreas, Biliary and Related
Cancer Center offers much more:
multidisciplinary diagnosis and
treatment, groundbreaking clinical
research, and active involvement in
community events — such as Amy’s
Ride/Run/Walk in Quakertown (May
20) and Pancreatic Cancer Action
Network’s PurpleStride (November 4).
New Multidisciplinary Pancreatic
Cancer Clinic
When pancreatic cancer is suspected,
many patients and their families feel
overwhelmed. In addition to the
emotional impact, patients may have to
schedule several appointments to see
primary doctors and gastroenterologists,
as well as surgeons, medical oncologists
and radiation oncologists. At our
Multidisciplinary Pancreatic Cancer
Clinic, all relevant clinicians gather
each Monday afternoon to review
cases and see patients — providing
the convenience of multiple
appointments during a single visit.

for Research in the Department of
Surgery, has been building a worldclass pancreatic cancer research
program. Dr. Brody specializes in
studying the molecular basis of
cancer development and progression,
targeted therapy and personalized
medicine. As a translational researcher,
he steers the research trajectory of
the Brody Laboratory while serving
as an advisor/collaborator to all
levels of trainees as well as our
practicing surgeons, including Drs.
Harish Lavu and Jordan Winter.
Ongoing Clinical Trials
Harish Lavu, MD, FACS, is leading the
Whipple Accelerated Recovery Pathway
(WARP) trial aimed at supporting faster
recovery from pancreatic surgery. In
2007, the team conducted a similar
study that established the seven-day
“Critical Pathway” standard at Jefferson.
The WARP trial — initiated in late 2015
and with nearly 70 patients enrolled
to date — is testing a five-day pathway.
The protocol incorporates in-hospital
physical therapy, specific dietary
recommendations and rigorous
monitoring following discharge.

Our multidisciplinary pancreatic cancer team includes surgeons, GI specialists, medical oncologists,
radiation oncologists, advanced practice nurses, research scientists, residents, postdoc fellows, graduate
students, clinical research coordinators and nutritionists.

“In Asia, average hospital stay for pancreatic surgery patients is 21 days.
In Europe, it’s 14 days. In most U.S. hospitals, it’s 12 to 14 days. Here at
Jefferson, our current seven-day stay requires tremendous coordination
across the Surgery, ICU and Nursing teams. With the WARP trial, we are
trying to do something few others have consistently been able to do:
improve outcomes by safely discharging Whipple procedure patients
after just 5 days.
“Why are shorter hospital stays better? Research has shown that being in a hospital when you
aren’t critically ill actually delays healing and exposes patients to hospital-acquired infections.
We want to prepare our patients to leave the hospital as quickly as possible so they can recover
safely and more rapidly in the comfort of their own homes.”

Development of a National Cancer
Institute Funded Research Program

Meanwhile, Jordan M. Winter, MD,
FACS, is tackling a perennial patient
query: “Can pancreatic surgery make
the cancer ‘spread’?” To explore this
topic, Dr. Winter is leading the Water
or Saline at High Volumes (WASH)
trial that is testing the use of 10 liters of
plain water or salt water for abdominal
washing immediately following removal
of the tumor. Current practice uses
just one or two liters of saline at the
conclusion of the procedure. The
study, started in April 2016 with more
than 100 patients enrolled to date,
aims to expand to other sites and
enroll 800 patients.

Since his recruitment in 2006,
Jonathan Brody, PhD, Vice Chair

For more information, go to
Jefferson.edu/Pancreas.
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The Spring of
2017…Change
and Hope
There is excitement in the air at Jefferson this spring. We had a superb
“Match” on March 17, and will be welcoming 6 terrific categorical
general surgery residents come July. The Philadelphia Phillies just
completed spring training well above .500, and there are high hopes
for an improved year. In late April, the American Surgical Association −
co-founded by our very own Dr. Samuel D. Gross (Chair of Surgery,
1856-1882) − hosted their 137th Annual Meeting here in Philadelphia.
As part of the social program, attendees toured Lubert Plaza in the heart
of our Center City campus, which includes the magnificent Samuel
Gross Monument by Alexander Calder.
Jefferson Health continues to sustain momentum towards further
expansion, with the planned addition of Kennedy Health in New Jersey
and Philadelphia University to our Jefferson family soon. Some work
is already underway with Philadelphia University (see the Enterprise
Integration column), taking advantage of their expertise in creative
design, innovation, and space planning. Add to this the work being done
at our Center City, Abington and Aria campuses by our 7 surgical 2.0
Integration teams focusing on patient-centered, highest quality care…
much is happening.
April 1 marked the launch of our Wave 2 EPIC implementation
(inpatient EPIC) at our Jefferson Hospitals in Center City and on our
Methodist campus. The power of this electronic health record (EHR)
is quite amazing. Patients are being encouraged to sign up online for
the “MyChart” patient portal, we are linked to other organizations via
the Care Everywhere platform, and we now have one unified EHR for
our outpatient and inpatient environments. As you might imagine,
the surgical residents have embraced this new technology with great
enthusiasm, while at least some of us (attending surgeons) are finding
we have to work a bit harder to become facile. We look forward to
further optimization of these systems, so that we can truly see the
power of this far reaching, multi-layered EHR.
Please enjoy the various articles which compose this issue and
keep up with our news on Facebook.com/JeffersonSurgery and
Twitter@JEFFsurgery in between issues.

In the Spotlight

Advanced practice nurses Liezl DiDonato, Chuck
Rowland, Sung Whang, Sophie Mintz, Lori Pelligrino,
Dana Ovadia, Theresa Yeo, Ling Fan, Linda Martino,
and Shawnna Cannaday

In September, 10 advanced practice nurses
from the Department of Surgery gathered for
a lunchtime kick-off meeting to form a Nurse
Practitioners (NPs) & Physician Assistants (PAs)
Professionalism and Scholarship Working
Group. This initiative is an important career
development component and has been
meeting on a monthly basis to discuss issues
in clinical practice, explore potential clinical
research projects, foster CV development,
and address professional practice concerns.
Thus far, two projects have been submitted
for small grant consideration, several
presentations have been developed and two
members are collaborating on publishing an
online continuing education module for NPs.
All Department of Surgery NPs
and PAs are invited. Please contact:
theresa.yeo@jefferson.edu.

A December meeting, led by Stephen Spinelli, Jr, PhD, President of Philadelphia University, and Charles J. Yeo, MD,
Chair of Surgery at Jefferson (seated, 3rd and 4th from left), gave faculty and staff from both institutions an
opportunity to brainstorm about future collaborations.

Department of Surgery and Philadelphia University
Lay Groundwork for Collaboration Prior to Merger
On the surface, the proposed merger
of Thomas Jefferson University and
Philadelphia University will create one
comprehensive institution focused
on professional education in health,
science, architecture, design, fashion,
business and engineering. In practice,
it will integrate different models of
thought and diverse approaches to
studying and solving problems —
enabling us to reimagine a new kind
of education for the jobs of the future.
The Combination Agreement was
signed by both institutions’ Boards
of Trustees in September 2016.
Although the merger isn’t expected
to be completed until later this year,
the Department of Surgery isn’t
waiting to initiate collaborations with
Philadelphia University. With Gerald
Isenberg, MD, FACS, Professor and
Director of the Surgical Undergraduate
Education Program and Colorectal
Residency Program, serving as the
Department’s liaison, the team is
already identifying innovative ways
to blend resources and expertise.
Dr. Isenberg recalls the first “road
trip” that department clinicians and
researchers took last December to
the Philadelphia University campus
in the East Falls section of the city:
“The facilities were amazing, and
there was a palpable excitement as
we toured the campus. Philadelphia
University works with huge companies
around the world. They have the
ability to make virtually anything right
there on the campus.”
He sees tremendous potential to apply
those capabilities to further refine
the field of surgery — from process
workflows to physical instruments
used to operate. In fact, one of the
ideas under consideration is a oneyear Fellowship in which a Department
of Surgery resident would spend his
or her research year studying surgical

process and design problems at
Philadelphia University.
“This would be an opportunity to
infuse fresh perspective to steps that
we take for granted,” Dr. Isenberg
explains. “We want to be challenged —
to strip away ‘that’s how we’ve always
done it’ thinking.”
Building on work already underway
at Jefferson, Scott Cowan, MD, FACS,
Associate Professor and Vice Chair for
Quality, is working with Philadelphia
University on rethinking patient rooms.
The team is tapping into Philadelphia
University’s expertise in architecture,
design and building materials to
analyze patient room design and
workflow. Combined insights and
recommendations could help on a
number of fronts — from improving
prevention of healthcare-acquired
infections to reducing patient fall risk.
“We have an extraordinary opportunity
to work together to improve the
environment of care for our patients,”
he says. “Philadelphia University’s
expertise clearly complements what
we’re doing here in the hospital in terms
of achieving the highest quality of care.”
Dr. Isenberg notes that the merger will
also benefit Philadelphia University
students, with unprecedented access
to the surgical world helping them
learn how surgeons approach and
solve problems.
“An integrated Philadelphia University
and Thomas Jefferson University
allows us to reimagine education in
a way that launches students into the
careers of their passion in a bigger,
bolder way,” says Philadelphia University
President Stephen Spinelli, Jr, PhD.
“We will prepare students for careers
of the 21st century, with an emphasis
on scientific and applied research,
design thinking and discovery.”
For more information, go to
wordpress.philau.edu/powered.

On the Job

Changing Lives Through Research

Clinical Studies Target Fewer Complications,
Better Outcomes for Vascular Surgery
Two studies at the Jefferson
Vascular Center (JVC) are assessing
innovative methods to reduce risk of
complications — and increase positive
outcomes — for vascular surgery
patients. Here, Paul DiMuzio, MD,
FACS, William M. Measey Professor
of Surgery and Co-Director, Jefferson
Vascular Center, reviews what both
studies mean for patient care.

Andrea DelMastro

‘Game-changer’ for groin wounds
As Dr. DiMuzio explains, groin incisions
in vascular surgery are a source of
significant morbidity and healthcare
costs. When groin wounds become
infected, patients may have to be
readmitted and undergo additional
surgery. Some patients are at greater
risk because of diabetes and obesity,
others because of the surgical
technique required for their treatment.
In exploring ways to decrease groin
wound infections in high-risk patients,
the JVC identified a possible solution
in PrevenaTM — a sponge covered
in adhesive that attaches to a small
suction device. The suction device
removes fluids from the region,
helping reduce the risk of infection.
Already FDA-approved, Prevena is
used by cardiac surgeons for sternal
incisions and by orthopedic surgeons
in total joint replacements.
“No one had conducted a prospective
randomized trial to determine if
Prevena is a viable option for highrisk groin wounds,” he says. “We
were the first.”
The results of Jefferson’s two-year
study — which will be presented
later this Spring at the 2017 Annual
Meeting of the Society for Vascular
Surgery in San Diego — showed a
significant reduction in infections
and re-admissions. Hospital costs
declined by an average of $6,000
per patient.

We are now using [the
Prevena] device for every
patient with high-risk
groin incisions, and
we expect it to become
a standard of care
everywhere once the
findings are published.

The Jefferson Vascular Center surgeons, Drs. Paul DiMuzio, Dawn Salvatore and Babak Abai, rely on the support of
advanced practice nurses Meghan McCullough, MSN, RN, FNP, AGACNP, and Cara Staley, MSN, RN-BC, AGACNP-BC
(on either side of Dr. Salvatore) to manage the Prevena and ROADSTER 2 clinical trials.

“We are now using this device for
every patient with high-risk groin
incisions, and we expect it to become
a standard of care everywhere once
the findings are published,” he adds.
“It’s a game changer.”
In February, Megan Lundgren, MD,
a third-year General Surgery resident
and Sidney Kimmel Medical College
alumna, presented the study at the
Philadelphia Academy of Surgery’s
Annual Surgical Research Competition.
Dr. Lundgren, who helped enroll and
care for trial participants, won the
inaugural Chris Tzarnas Surgical
Research Award for the work.
Follow-up trial of new treatment
for carotid artery disease
Following the promising multi-center
ROADSTER trial, the ROADSTER 2 trial
is observing and evaluating real-world
results of a newly approved procedure
for treating carotid artery disease.
The most widely used treatment
for carotid artery disease has been
the carotid endarterectomy (CEA)
procedure, in which plaque is surgically
removed from the blocked artery.
For patients who may be at high
medical or anatomic risk for carotid
endarterectomy, carotid stenting
may be a better option. Though both
procedures are generally safe, heart
attack risk is higher with CEA, while
stroke risk is higher with stenting.
Trans-carotid Artery Revascularization
(TCAR) is designed to lower both
risks, and the initial ROADSTER trial
demonstrated its success.

“The TCAR procedure is a hybrid
of the other two treatments,” Dr.
DiMuzio says. “It places a carotid
stent through a minimally invasive
incision in the carotid artery at the
level of the neck. Blood flow in
the artery is temporarily reversed
to protect the brain from plaque
fragments that may come loose
during the procedure. A stent is then
inserted into the blood vessel to
support the artery walls and prevent
blockage or collapse.” Dr. DiMuzio
adds that stent deployment via access
directly through the common carotid
artery avoids the need to traverse the
aortic arch with catheters, which can
lead to embolic stroke.
Though approved by the FDA,
the TCAR procedure will not be
marketed until the ROADSTER 2 trial
is completed. To date, Jefferson is
the first and only study location in
the Philadelphia area. Dr. DiMuzio
and his team have already performed
the TCAR procedure and are actively
enrolling more patients.
“Nationally, the study is more than
halfway to completion — and the
TCAR procedure is on its way to
becoming an exciting new standard
of care for carotid artery disease,”
he says.
For more information, contact
the Jefferson Vascular Center
at 215-955-8304 or visit
Jefferson.edu/JVC.

Since joining the Department of Surgery
in 2001 as an administrative assistant in
the Division of Transplant Surgery, Andrea
DelMastro has moved to our 1300 Wolf Street
Office on the Methodist Campus. Born and
raised in South Philly, she has returned and
served as the Department’s practice manager
there for the past five years.
At Methodist, Andrea oversees day-to-day
operations of 14 providers and a team of
registrars, medical assistants and nurse
practitioners. The practice includes several
specialties within the Department of Surgery:
Bariatric, Breast, Colorectal, General, Thoracic
and Vascular Surgery & Vascular Medicine.
The services provided there include more than
just surgical consultations, as several other
outpatient services are offered, including
vascular ultrasound, minimally invasive vein
closure, and wound care.
During the last few years she has been
active at both campuses taking on a number
of departmental projects: she is currently
the Department’s lead for the JeffConnect
telehealth program and serves as a ‘super
user’ for the EPIC Electronic Health Record
implementation.
Another of DelMastro’s long-term projects
is contributing to the Methodist Hospital
Division’s Surgery White Paper. The purpose
of the ongoing initiative: to identify ways to
improve both patient experience and overall
surgical patient throughput at Methodist.
To date, such improvements have included
adding a room for private family surgical
consultations and staffing a patient registrar.
She appreciates the diverse challenges of
her work: “Every day is different,” she says.
“I juggle clinic hours, department projects, as
well as the unique needs of staff and patients
that come up daily.” DelMastro strives to
make sure her employees are engaged, as
she believes that “makes all the difference
in patient care.”
Above all, Andrea values being part of the
Methodist community: “I love that I get to
work in an office where I know the majority
of my patients from the neighborhood. It’s
world-class care – with a real hometown feel.”

For an appointment with a Jefferson Surgeon, call 1-800 -JEFF - NOW

Those Who Give

Patient-Benefactors Support New Kidney Transplant Center
December 14, 2017 was a landmark day at
Jefferson: the ribbon cutting ceremony of
the Nicoletti Kidney Transplant Center at
Jefferson. This milestone venture – bringing
together research, education and clinical care
in one space – came to fruition thanks to
a $2.5 million lead gift from the Robert V.
Nicoletti Family Trust. The Center emphasizes
living donor transplantation, something that
is very personal to the Nicoletti family.

In 2004, Pennye Goodman received a living donor
kidney transplant thanks to her donor and brother,
Gregory Tettemer, and their care team at Jefferson.
On December 14, Pennye and her husband, Phil, cut
the ribbon to their Exam Room named for Gregory in
the Nicoletti Kidney Transplant Center located at the
corner of 9th and Chestnut Streets in Center City.

In early 2006, Jefferson doctors determined
that the patriarch of the family, businessman
and philanthropist Robert (Bob) V. Nicoletti,
needed a kidney transplant. Seven members
of his family immediately volunteered to donate
a kidney. Ultimately, only one was deemed
compatible: Bob’s youngest daughter, Lori
Nicoletti Peruto, Esq. This life-saving kidney
gave Bob – who passed away in February 2016
at 85 years-old – another 10 loving years with
his children and grandchildren.

Inspired by the care they received at Jefferson,
the Nicolettis became steadfast and generous
supporters of the Jefferson Transplant Institute.
In late 2015, Bob and his three children, Mark
R. Nicoletti, Sr., Lori Nicoletti Peruto, Esq., and
Donna Nicoletti Ferrier, along with their spouses,
provided the leadership gift to name the new
Center. This kicked off a campaign supported
by other grateful patients, Jefferson leadership
and community partners to build a more robust
living donor kidney transplant program.

Living donor transplants generally
work better and last almost twice as
long as deceased donor transplants.
Pennye Goodman was also inspired to give
back after receiving a life-saving kidney in
2004 from her brother, Gregory Tettemer.
“Through the generosity of my brother, the skills
of the Jefferson team and the grace of God, I
have been blessed with many years of excellent
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Living donor transplants generally work
better and last almost twice as long as
deceased donor transplants. With more than
600 patients on Jefferson’s organ transplant
wait list, this campaign and the resources
provided to patients and families in the
Nicoletti Kidney Transplant Center come at
a critical time. The Center not only simplifies
the patient journey, but it also expands
our dedicated multidisciplinary team and
supports clinical research.
To learn about supporting the Nicoletti
Kidney Transplant Center at Jefferson, visit
Jefferson.edu/GiveJTI or contact Kelly Austin
in the Office of Institutional Advancement
at 215-955-6383.
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health. We are proud to support this new
Center that will ease the burden of the
transplant journey for patients and their families.”
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News in Brief
Alec Beekley, MD, FACS (Division of Acute Care Surgery), and
John Entwistle, MD, FACS (Division of Cardiothoracic Surgery),
have each been promoted to Professor of Surgery.
Howard Todd Massey, MD, has joined
the Division of Cardiothoracic Surgery as
the Surgical Director of Cardiac Transplant.
Dr. Massey completed his general surgery
residency at the University of Louisville
and his thoracic and cardiovascular
surgical residency at the University of
Texas Southwestern. He then completed
a fellowship in Heart and Lung Transplantation and Adult Cardiac
Surgery at the Duke University Medical Center. Dr. Massey is dualcertified in Surgery and Thoracic Surgery. Under the leadership of
Dr. Massey and Andrew Boyle, MD, Medical Director of Advanced
Heart Failure, Jefferson has reactivated its Heart Transplant
Program with the United Network for Organ Sharing (UNOS).

On March 1, the Jefferson Center for Injury Research and
Prevention (JCIRP) proudly hosted the 2017 Vision Zero for
Philadelphia Conference presented by the Bicycle Coalition
of Greater Philadelphia and Uber. Stanton B. Miller, MD, MPH,
Founding Director of JCIRP, welcomed an audience including
urban designers, transportation planners, and representatives
from AAA, AARP and several city and state agencies. Participants
will collaborate and implement research-based initiatives to
eliminate traffic fatalities and serious injuries by 2030, through
education, engineering and enforcement. JCIRP was established
in 2013 within the Division of Acute Care Surgery, led by Murray J.
Cohen, MD, FACS, Director of the Level I Regional Resource Trauma
Center at Jefferson.
Charles J. Yeo, MD, FACS, Samuel D. Gross Professor and Chair
of Surgery, has been named Senior Vice President and Chair–
Enterprise Surgery for Jefferson Health, and Editor-in-Chief of
the new Journal of Pancreatic Cancer.

For more news about the Department follow us on social media.    JeffersonSurgery   
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On April 29, Theresa Pluth Yeo, PhD,
MPH, ACNP, Adjunct Associate Professor
in the Jefferson College of Nursing and
Co-Director of the Jefferson Pancreas
Tumor Registry received the 2017
Distinguished Alumni Award from Cornell
University– New York Hospital School
of Nursing.
Save the Date: Jefferson will host the 12th Annual Pancreatic
Cancer and Related Diseases Symposium on Saturday,
November 11, 2017 from 9 am to 2 pm. The event gives patients
and their loved ones an opportunity to connect with expert
physicians, scientists and staff and learn about the latest
developments in research and treatment. Seating is limited for
this free event. Registration is required. Please contact, Kelly Austin
at 215-955-6383 to request an invitation. For more information,
visit Jefferson.edu/PancreasEvent.
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